This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Cochlear Limited, Espci Paris. Active years: 2026.
Company Filing History:
1 out of 1,203 
1 out of 1 Years Active: 2026
Title: Léa Milenkovic: Innovator in Cochlear Implant Technology
Introduction
Léa Milenkovic is a prominent inventor based in Paris, France. He has made significant contributions to the field of auditory technology, particularly through his innovative work on cochlear implants. His dedication to improving hearing solutions has led to the development of a unique patent that enhances the functionality of cochlear hearing aids.
Latest Patents
Léa Milenkovic holds a patent for a cochlear implant with a multi-layer electrode. This cochlear hearing aid system is designed to provide electrical stimulation to the auditory nerve fibers of a recipient. The system includes a microphone that captures acoustical signals and converts them into audio signals. A signal processor unit processes these audio signals, while an electrode lead with multiple electrodes stimulates the auditory nerve fibers based on the processed audio signals. The electrode lead features an electrode carrier made of silicone, loaded with dexamethasone, and includes a first layer of gelatin that is chemically cross-linked on the silicone surface, embedding dexamethasone sodium phosphate. A second layer of gelatin is also included, which is physically cross-linked onto the first layer.
Career Highlights
Throughout his career, Léa Milenkovic has worked with notable organizations, including Espci Paris and Cochlear Limited. His experience in these companies has allowed him to refine his skills and contribute to advancements in cochlear technology.
Collaborations
Léa has collaborated with esteemed colleagues such as Dominique Hourdet and Yvette Tran. Their combined expertise has fostered an environment of innovation and creativity in the field of auditory solutions.
Conclusion
Léa Milenkovic's contributions to cochlear implant technology exemplify his commitment to enhancing the quality of life for individuals with hearing impairments. His innovative patent and collaborative efforts highlight the importance of continued research and development in this vital area of healthcare.